KLK3 and prostate carcinoma: For example, the risk of prostate cancer for patients with “normal” PSA levels is estimated at 6.6% for levels 0 to 0.5 ng/mL and climbs up to 26.9% for levels 3.1 to 4 ng/mL [7].